News

SPOHNC is very pleased to announce that the long-anticipated and updated version of We Have Walked in Your Shoes: A Guide to Living with Oral, Head, and Neck Cancer Second Edition is now available!

Women with HR-positive breast cancer who remained premenopausal after receiving chemotherapy had a lower risk of disease recurrence when adding ovarian suppression to adjuvant exemestane or-to a lesser extent- tamoxifen compared with standard tamoxifen alone, according to results from the phase III SOFT trial.

The FDA has approved lenalidomide (Revlimid) plus dexamethasone in newly diagnosed patients with multiple myeloma based on findings from the phase III FIRST trial.

A study involving more than 1000 patients enrolled in randomized clinical trials has found that patient and physician assessment of treatment toxicities can vary greatly, and they are frequently under-reported by physicians.

A study has found that a large number of women diagnosed with breast cancer know little about the basic characteristics of the cancer:

The Center for Medicare & Medicaid Services (CMS) has announced a new initiative which it hopes will improve the coordination and quality of cancer care for Medicare patients with cancer while also reducing costs.

A new analysis has shown that taking hormone replacement therapy to alleviate symptoms associated with menopause significantly increases the risk of developing the two most common types of ovarian cancer, even if the therapy is only taken for a few years.

Camille Grammer, Real Housewife of Beverly Hills and one-year survivor of endometrial cancer, will lend her voice and celebrity to raising awareness about gynecologic cancers by serving as Chair of the 2015 National Race to End Women's Cancer to be held Sunday, Nov. 8 in Washington, D.C.

Older adults are at higher risk for interactions

Although some physicians may blame patient demands for the increase in medical costs, a new study has shown that cancer patients rarely push their doctor to run unnecessary tests and treatments.

In February 2002, I was diagnosed with stage I melanoma.

When survivors of colorectal cancer smoke, their risk of death more than doubles compared with their counterparts who do not smoke, a new study by researchers at the American Cancer Society has found.

The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.

This section provides you with brief background information about kidney cancer and some immediate resources that may be helpful.

Part II of a series on these new agents

When a cancer diagnosis occurs during this time, physicians and nurses must take special care to discuss certain issues that they may not discuss with pediatric or adult patients.

The big difference in progression-free survival seen in pivotal trial data propelled palbociclib to its accelerated FDA approval for the treatment of metastatic breast cancer, bringing with it the potential for the drug to quickly become adapted as the new standard of care, Brian Wojciechowski, MD, said.

Thanks to The Cancer Genome Atlas (TCGA) Research Network, researchers now have a better understanding of genomic alternations in head and neck cancers.

The recent extended approval of ibrutinib for the treatment of Waldenström's macroglobulinemia (WM), the disease's first FDA-approved therapy, has provided new hope for patients with the orphan disease.

Part I of a series on these newly approved agents.

During President Barack Obama's State of the Union Address last week, he announced a nationwide Precision Medicine Initiative that would help cure diseases such as cancer and diabetes. This morning he built on his announcement and outlined a $215 million plan to help develop precision medicine nationwide.

Women diagnosed with early-stage breast disease have a variety of decisions to make regarding their treatment options. For example, some women may be eligible for breast-conserving surgery, which typically includes a lumpectomy followed by radiation.

When motivating people to get screened for cancer, fear may not be the best way to do it.

Cancer Hope Network's TACT program incorporates clinical trials into the criteria that is considered when making those matches.

A new study has found that while the breast cancer prevention drug tamoxifen's benefits outweigh its risks, the drug isn't right for all women.

Few clinicians are asking about their use and most lack knowledge about them.

After many (ten!) marathon attempts over several (six!) years, I was able to reach my qualifying time for the Boston Marathon.

January is National Mentoring Month, a great time to spotlight the unique matching process whereby Imerman Angels partners individuals seeking cancer support with a "Mentor Angel."